Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Eschenberg
Michael Eschenberg
Medicine
Epratuzumab
Lymphoma
Pharmacokinetics
Non-Hodgkin's lymphoma
4
Papers
762
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
2012
Journal of Clinical Investigation
Victoria Shalhoub
Edward Shatzen
Sabrina Ward
James O. Davis
Jennitte Stevens
Vivian Bi
Lisa Renshaw
Nessa Hawkins
Wei Wang
Ching Chen
Mei-Mei Tsai
Russell C. Cattley
Thomas J. Wronski
Xuechen Xia
Xiaodong Li
Charles Henley
Michael Eschenberg
William G. Richards
Show All
Source
Cite
Save
Citations (313)
Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma: Phase I/II Clinical Trial Results
2004
Clinical Cancer Research
John P. Leonard
Morton Coleman
Jamie Ketas
Amy Chadburn
Richard R. Furman
Michael W. Schuster
Eric J. Feldman
Michelle Ashe
Stephen J. Schuster
William A. Wegener
Hans J. Hansen
Heather Ziccardi
Michael Eschenberg
Urte Gayko
Scott Z. Fields
Alessandra Cesano
David M. Goldenberg
Show All
Source
Cite
Save
Citations (214)
Phase I/II Trial of Epratuzumab (Humanized Anti-CD22 Antibody) in Indolent Non-Hodgkin’s Lymphoma
2003
Journal of Clinical Oncology
John P. Leonard
Morton Coleman
Jamie Ketas
Amy Chadburn
Scott Ely
Richard R. Furman
William A. Wegener
Hans J. Hansen
Heather Ziccardi
Michael Eschenberg
Urte Gayko
Alessandra Cesano
David M. Goldenberg
Show All
Source
Cite
Save
Citations (235)
Phase I /II T rial o f E pratuzumab ( Humanized A nti-CD22 Antibody) i n I ndolent N on-Hodgkin's L ymphoma
2003
John P. Leonard
Morton Coleman
Jamie Ketas
Amy Chadburn
Scott Ely
Richard R. Furman
William A. Wegener
Hans J. Hansen
Heather Ziccardi
Michael Eschenberg
Urte Gayko
Alessandra Cesano
David M. Goldenberg
Show All
Source
Cite
Save
Citations (0)
1